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ABSTRACT 
A  graded series of drug-resistant  Chinese hamster sublines has been examined for 
biochemical changes accompanying resistance to actinomycin D. The most highly 
resistant subline, DC-3F/AD X, is maintained  at  10 ~tg/ml of the antibiotic.  It was 
shown  that  over  250  times  more  actinomycin  D  is  required  to  inhibit  RNA 
synthesis in this subline than in the parental DC-3F line. The DC-3F/AD X  subline 
was  also  shown  to  have  a  somewhat  reduced  capacity  to  transport  uridine  as 
compared  to  parental  cells.  Sensitive  cells  took  up  over 50 times  more tritiated 
antibiotic  than  the  most  resistant  cells,  as determined  in  a  l-h  assay.  Uptake  of 
actinomycin  D  was  shown  to  be  temperature-dependent  in  both  resistant  and 
sensitive  cells  and  was not influenced by various metabolic inhibitors.  Resistance 
could  not  be  explained  by  a  rapid  uptake  and  release  of  the  antibiotic,  as 
demonstrated  in  efflux  experiments,  or  by  its  metabolism.  In  addition,  highly 
resistant cells which are cross-resistant to puromycin were shown to have a reduced 
capacity  to  take  up  labeled  puromycin.  These  studies  provide  further  evidence 
indicating  that  the  mechanism  of  resistance  to  actinomycin  D  is  reduced 
permeability  to drug  and  suggesting  that  cell  membrane  alteration  accounts  for 
resistance  to both  actinomycin D  and puromycin. 
Cellular  resistance  to  actinomycin  D  has  been 
developed in a variety of mammalian cells in vitro 
(1,  2, 3, 4).  Although the mechanism of action of 
actinomycin  D  has  been  elucidated  (5),  various 
parameters of natural or acquired resistance, mode 
of entry, and factors which regulate sensitivity to 
the  antibiotic  still  remain  obscure.  The  surface 
properties  of the  resistant  Chinese  hamster  cells 
have been shown to be modified when compared to 
drug-sensitive  parental  cells  (6,  7,  8).  We  have 
previously  observed  that  striking  morphological 
changes indicative  of reversion to normal pheno- 
type,  as  well  as  reduction  or  loss  of oncogenic 
potential,  accompany development  of high  levels 
of resistance to actinomycin D in Chinese hamster 
cells  in  culture (1).  In the present  study, some of 
the  biochemical  properties  relevant  to macromo- 
lecular biosynthesis and transport that accompany 
resistance to actinomycin D were investigated with 
the  intent  of gaining  further  insight  into  mech- 
anisms of resistance. 
MATERIALS AND METHODS 
Cells and Methods of Culture 
Details of the origin of the Chinese hamster cells and 
of the resistant sublines have been given previously (3). 
Monolayer cultures were maintained in Eagle's minimal 
medium (MEM)  supplemented with 10% fetal calf se- 
rum,  streptomycin  (100 /~g/ml),  and  penicillin  (100 
U/ml). Resistant sublines were grown without drug for 
l0  15 days before experimental analysis. Exponentially 
growing cells were used throughout this study. Cells were 
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Electronics,  Inc.,  Fine  Particle Group,  Hialeah,  Fla.). 
Cells  for  experiments  were  grown  in  25-cm 2  flasks 
(Falcon Plastics, Division of B-D Laboratories, Inc., Los 
Angeles, Calif.), and  in  a standardized  mixture of CO~ 
and  air.  Routinely, after the culture medium was  aspi- 
rated,  the  cells  were  washed  several  times  with  Dul- 
becco's  phosphate-buffered  saline  (PBS)  without  cal- 
cium and magnesium, and were detached from the poly- 
styrene flasks  with 0.02% (0.5  mM) sodium ethylenedi- 
amine tetraacetic acid (EDTA). 
Development of actinomycin D-resistant sublines  was 
described in  a  previous report  (3).  Development of the 
daunomycin-resistant subline  DC-3F/DM XX, selected 
by direct exposure to daunomycin and maintained at  10 
/~g/ml,  was also described previously (9). The vincristine 
subline  DC-3F/VCRd  was  developed  by  similar 
methods, and is maintained with vincristine at a level of 
10 t~g/ml.  Response  of sensitive  parental  DC-3F cells 
and of resistant sublines  to actinomycin D, daunomycin, 
vincristine,  or  puromycin  was  determined  in  a  3-day 
assay system detailed elsewhere (3). The concentration of 
drug  required to  inhibit  growth  to  50%  of control (no 
drug)  is  reported  as  the  EDso  value.  Resistance  or 
cross-resistance to a  chemical agent is expressed  as the 
ratio of EDso values for resistance  to parental line. 
Isotopes and Chemicals 
Actinomycin D  was  obtained from Merck, Sharp  & 
Dohme,  Inc.,  West  Point,  Pa.  Tween  80  and  tritiated 
actinomycin  D  (8.4  Ci/mmol)  were  obtained  from 
Schwarz/Mann,  Div.  of  Becton,  Dickinson  &  Co., 
Orangeburg,  N.  Y.  Puromycin  dihydrochloride  was 
obtained  from  Sigma  Chemical  Co.,  St.  Louis,  Mo. 
[5-3H]Uridine  (25.7  Ci/mmol),  [methyl-3H]thymidine 
(6.7  Ci/mmol),  [8-1'C]adenine  (6.53  mCi/mmol), [me- 
thoxy-SH]puromycin dihydrochloride  (838 Ci/mmol), 
and  L-[4,5-aH]leucine  (5 Ci/mmol) were obtained from 
New England Nuclear, Boston,  Mass. All other reagents 
were the best grade commercially available. 
Analytical 
Uptake of tritiated actinomycin was determined essen- 
tially  as  described  previously  (2). Briefly,  cells  were 
exposed  to  tritiated  actinomycin  D  (2.0  /~Ci/ml,  2.0 
t~g/ml [1.6 x  10  e M], total external concentration) for 1 
h.  The  labeled  medium  was  aspirated  and  cells were 
washed  five times with PBS without calcium and magne- 
sium. The cells were then detached from the flasks  with 
0.02%  EDTA.  Flasks  were  rinsed  twice  with  2-ml 
portions of saline, and cells were collected by centrifuga- 
tion. The pellet was taken up in  1 ml water and counted 
in  a  Triton-toluene  scintillation  fluid.  Counts  are  ex- 
pressed  as counts per minute per  106 cells unless  other- 
wise stated. All samples were counted in a Packard liquid 
scintillation  spectrometer  (Packard  Instruments  Co., 
Inc., Downers Grove, I11.). 
RNA, DNA, and protein were measured, as described 
before (10), by determining the amount  of appropriate 
precursors incorporated into acid-insoluble  5% trichloro- 
acetic acid (TCA). The precipitates were filtered through 
Millipore  filters  (0.45  ~m  pore  size,  Millipore Corp., 
Bedford,  Mass.),  washed with several washes of 5% TCA, 
dried,  and  counted  in  Omnifluor  (New  England  Nu- 
clear).  Aliquots  of  the  TCA-soluble  material  were 
counted directly in a Triton-toluene scintillation fluid. 
RESULTS 
Morphological Characteristics  of 
Actinomycin D Resistance 
The  actinomycin  D-sensitive  parental  line, 
DC-3F (Fig.  l  a),  is a  spontaneously  transformed 
Chinese hamster line initially derived from normal 
lung fibroblast  populations  (3).  The growth prop- 
erties of this cell line reflect that of a malignant cell 
type,  with  an  apparent  lack  of density-dependent 
inhibition  of growth.  These  cells have  previously 
been  shown  to  be  tumorigenic  in  a  heterologous 
transplantation  system  (1).  Resistance  to  ac- 
tinomycin D  in Chinese hamster cells is accompa- 
nied by striking morphological changes. The mor- 
phological  manifestations  of  resistance  are  in- 
creased  cellular  adhesiveness  with  apparently 
stronger  cell-to-cell  interaction  and  cell-to-sub- 
stratum  adherence.  The  graded  series  of  ac- 
tinomycin D-resistant sublines (Fig.  1 b-d) tend to 
grow as flattened, oriented fibroblast-like popula- 
tions  with  apparently  more  adhesive  membranes, 
commensurate  with  increase  in  resistance  to  ac- 
tinomycin  D.  The  most  resistant  cell  line, 
DC-3F/AD  X,  is  nontumorigenic  (I)  and  mani- 
fests density-dependent inhibition of growth (Fig. 1 
d). 
Uptake  of  tritiated  antibiotic  by  DC-3F  and 
drug-resistant  sublines  was  measured.  The  sensi- 
tive parental  DC-3F line takes  up  about  50 times 
more  actinomycin  D  than  the  highly  resistant 
DC-3F/AD  X  within  a  l-h  time  period.  The 
sublines  with intermediate resistance,  DC-3F/AD 
II  and  DC-3F/AD  IV,  take  up  correspondingly 
less labeled  actinomycin  D  than do parental cells. 
Two  other  Chinese  hamster  lines,  which  were 
selected for resistance to vincristine and daunomy- 
cin,  DC-3F/VCRd  and  DC-3F/DM  XX  (9),  and 
which  are  cross-resistant  to  actinomycin  D,  also 
showed  reduced  uptake  of  tritiated  antibiotic. 
Previous  data  (3,  9)  based  on  biological  assays 
demonstrated  resistance to actinomycin  D  as well 
as  cross-resistance  to  a  variety of other  chemical 
agents. 
774  THE  JOURNAL  OF  CELL  BIOLOGY  •  VOLUME  63,  1974 FIGURE 1  Fixed monolayer cultures: (a) DC-3F; (b) DC-3F/AD II; (c) DC-3F/AD IV; (d) DC-3F/ADX. 
Stained with May-Griinwald-Giemsa.  x  75. 
Dose Response of Inhibition  of 
RNA  Synthesis 
The effect of actinomycin D on  RNA synthesis 
is shown in Fig. 2. The parental DC-3F cell line is 
most  sensitive  to  inhibition  of  RNA  synthesis 
while the highly resistant subline, DC-3F/AD X, 
requires  over  250  times  more  actinomycin  D  to 
inhibit  uridine  incorporation  into  RNA.  At  a 
concentration  of  50  /~g/ml  of  actinomycin  D, 
RNA  synthesis  is  inhibited  only  by  about  80%. 
Under  a  similar  set  of experimental  conditions, 
there  was  no  inhibition  of  DNA  synthesis  as 
measured  by  thymidine  incorporation  (data  not 
shown). 
In  order  to  assess  whether  the  rate  of  RNA 
synthesis is different in the resistant cells, apparent 
rates  of  synthesis  were  measured  by  following 
uridine  incorporation  into  RNA,  in  logarithmi- 
cally growing  cells  (Fig.  3).  It  appears  that  the 
relative rate of RNA synthesis in the DC-3F/AD 
lI  subline  is  consistently  slightly higher  than  in 
parental cells, while in the more resistant sublines 
it  is  somewhat  lower.  These  differential rates  of 
RNA  synthesis  cannot  be  adequately  accounted 
for by differences in growth rate since the popula- 
tion doubling times are: DC-3F, 13 h; DC-3F/AD 
II,  15 h;  DC-3F/AD  IV,  14.5 h; and DC-3F/AD 
X,  15 h (3). The possibility was considered that the 
DC-3F/AD X subline might be a transport variant 
for uridine uptake and, thus, that uridine incorpo- 
ration  was  not  a  reflection  of the  rate  of RNA 
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FIGURE 2  Concentration-dependent inhibition of RNA 
synthesis. Duplicate cultures  were incubated with ac- 
tinomycin D at the indicated concentrations for 30 min. 
Control  cultures  received no  actinomycin D.  To  all 
cultures [5-3H]uridine (0.1 ~Ci/ml; 25.7 Ci/mmol) was 
added and uridine incorporation into cold acid-insoluble 
material  was  determined  after  1 h,  as  described  in 
Materials and Methods. A, DC-3F; O, DC-3F/AD 1I; 
@, DC-3F/AD IV; and A, DC-3F/AD X. 
synthesis but rather  of a  limited capacity of the 
cells to take up uridine. Therefore, adenine incor- 
poration  into  DNA  and  RNA  was  measured. 
Again, it appeared that the apparent rate of RNA 
synthesis, as reflected by incorporation of adenine, 
is  lower  in  the  more  resistant  DC-3F/AD  X 
subline as compared to sensitive parental cells.  In 
order  to  clarify  whether  differences in  apparent 
rates  of  RNA  synthesis  were  due  to  decreased 
synthesis or reduced rate of uridine and, possibly, 
adenine transport, whole cell uptake and incorpo- 
ration  of  both  precursors  into  acid-soluble and 
insoluble fractions were  measured.  It  was  found 
that whole cell uptake and transport of uridine into 
the actinomycin D-resistant DC-3F/AD X cell line 
are markedly reduced on a  per cell basis and per 
total cellular protein (data not shown). This may, 
in part, account for the apparent differences in rate 
of RNA  synthesis. Reduced uptake  of uridine is 
not  due  to  density  inhibition of growth  in  this 
experiment, as the cell concentration was 3 ×  106 
cells per flask,  which  is  far below the  saturation 
density  of  resistant  cells  under  these  conditions 
(unpublished observations). Further, to exclude the 
possible  effects  of  density  inhibition of  uptake, 
sensitive and resistant cells were exposed to labeled 
uridine in suspension cultures and similar results 
were  obtained (data  not shown). Adenine uptake 
and  incorporation  are  also  reduced  in  the 
DC-3F/AD X  subline but not to the same extent 
as uridine. These data suggest that the actinomycin 
resistant  subline  DC-3F/AD  X  has  a  reduced 
capacity to  transport uridine. In another experi- 
ment it was found that the ribose content of both 
cell lines was similar on a  per milligram protein 
basis  (DC-3F,  0.299  mg  RNA/mg  protein  and 
DC-3F/AD X, 0.240 mg RNA/mg protein). Leu- 
cine  incorporation  into  protein  in  the  resistant 
DC-3F/AD X  subline was  only about  one-third 
the  rate  in  the  parental  DC-3F  cells.  This  is 
inconsistent with the growth rates of the two cell 
lines. In general, the DC-3F/AD X cells may have 
reduced  capacity to  accumulate small precursors 
as well as large molecules. 
Factors Affecting Uptake of Actinomycin D 
The concentration-dependent uptake of labeled 
actinomycin D is shown in Fig. 4.  It appears that 
at 3 h uptake of labeled antibiotic in parental cells 
is  approaching  steady-state  levels  at  concentra- 
tions of 2 and 5/zg/mi, while the resistant subline 
takes  up  an  extremely  small  amount  of  ac- 
tinomycin D even at a concentration as high as 20 
#g/ml. 
The effect  of the surfactant Tween 80 was used 
to measure enhancement of uptake of actinomycin 
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FIGURE  3  Rate  of  RNA  synthesis  in  sensitive  and 
resistant  cell  lines.  Logarithmically  growing  cells  were 
exposed to [5-3H]uridinc  (0.1/~Ci/ml;  1.0/zg/ml)  at time 
zero.  Duplicate  flasks  were harvested  and  uridinc  incor- 
poration  into RNA was determined as described previ- 
ously (9). A, DC-3F; O, DC-3F/AD 11; @, DC-3F/AD 
IV; and A, DC-3F/AD X. 
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FIGURE  4  "  Concentration-dependent uptake of [3H]ac- 
tinomycin  b  in  Chinese  hamster  cells  sensitive  and 
resistant to actinomycin D. Actinomycin D was added to 
DC-3F (1  ×  10 -2 #Ci/#g) and  to DC-3F/AD X  (5  × 
10 -2 #Ci/#g) at time zero. Uptake of actinomycin D was 
determined  as described in Materials and  Methods. &, 
DC-3F; and A, DC-3F/AD X. 
D  at levels which produce no obvious morphologi- 
cal changes (6).  A  concentration of 0.075% Tween 
80  produced  an  approximately  fivefold enhance- 
ment  of  uptake  of  actinomycin  D  in  the  highly 
resistant  DC-3F/AD X  cells. 
To  gain  some  insight  into  the  process  of  ac- 
tinomycin  D  accumulation  in sensitive and  resist- 
ant  Chinese  hamster  cells, the effect of tempera- 
ture  was  determined.  Both  sensitive  cells  and 
highly  resistant  cells  selected  by  actinomycin  D 
exhibit  temperature-dependent  uptake  of  antibi- 
otic. Drug-sensitive DC-3F cells take up about 450 
times more  actinomycin  D  at  37°C than  at 4°C. 
Resistant  cells  also  exhibit  temperature  depend- 
ence even though  uptake  is less than  for parental 
cells. That uptake of actinomycin D may not be an 
energy-dependent  process  is  exemplified  by  the 
fact that  no inhibition  of uptake  was observed in 
the  presence  of potassium  cyanide  or dinitrophe- 
nol. 
Efflux  experiments  with  cells  prelabeled  with 
actinomycin  D  indicate  that  the excretion rate  in 
resistant  cells is much less rapid  than  in  sensitive 
cells (Fig.  5).  It must  be noted that  resistant cells 
cannot  be loaded  with drug to the same extent as 
sensitive cells. However, resistance to actinomycin 
D is apparently not due to rapid uptake and release 
of antibiotic (see also  Fig. 4). 
Chinese hamster  cells which have been selected 
for  resistance  to  actinomycin  D  are  also  cross- 
resistant to a variety of other drugs within a certain 
molecular weight range, irrespective of their mode 
of  action  (3).  The  resistant  line,  DC-3F/AD  X, 
was  found to be cross-resistant  to puromycin  (3). 
In the present study,  response of DC-3F/AD X  to 
puromycin  was  determined  in  the  assay  system 
previously  described  (3).  An  EDs0  value  of  270 
#g/ml  was  obtained;  cross-resistance  of 
DC-3F/AD X  to puromycin is 116-fold. As shown 
in  Fig.  6,  cross-resistance  may be  attributed  to  a 
reduced  capacity  for  uptake  of  puromycin.  In 
another experiment, pretreatment of resistant cells 
with  puromycin  at  a  concentration  of 500  #g/ml 
for 30 min followed by exposure to tritiated leucine 
for  1  h  showed  only  60%  inhibition  (data  not 
shown). 
In order to eliminate the possibility that  resist- 
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Rate of release of [3H]actinomycin  D. Cul- 
tures of DC-3F were treated with [3H]actinomycin D (0.5 
#Ci/ml; 2 #g/ml) for 1 h and DC-3F/AD X (1 #Ci/ml; 2 
/~g/ml) for 2 h. Medium containing labeled actinomycin 
D was removed and flasks were rinsed  three times with 
fresh medium. Conditioned medium was then added back 
to  the  flasks  and  uptake  of  [3H]actinomycin  D  was 
determined  as described in Materials and  Methods. &, 
DC-3F and A, DC-3F/AD X. 
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FIGURE 6  Uptake of[3H]puromycin. Growing cultures 
were exposed to  [methoxy-SH]puromycin dihydrochlo- 
ride  (2  #Ci/ml  and  2  #g/ml  unlabeled puromycin). 
Uptake  of puromycin was  measured as described for 
actinomycin D. A, DC-3F and A, DC-3F/AD X. 
ance to actinomycin D is due to metabolism of the 
antibiotic, sensitive and  resistant  cell  lines were 
exposed to labeled actinomycin D for 48 and 72 h, 
respectively.  The  actinomycin  D  was  extracted 
from the cells and chromatographed with authen- 
tic  standard  labeled  antibiotic.  No  differences 
could be seen with either the sensitive or resistant 
cell  extracts  (data  not  shown).  Therefore,  the 
resistant  cells  are  not  able  to  metabolize  ac- 
tinomycin D to a less toxic metabolite. 
DISCUSSION 
Chinese  hamster  cells  in  culture  with  acquired 
resistance to actinomycin D exhibit a trend toward 
normal  growth  properties  as  compared  to  the 
spontaneously transformed  parental cell  popula- 
tion (1). The morphological alterations coincident 
with resistance to actinomycin D  are exemplified 
by a  change from typical "malignant" cell types, 
to more flattened, oriented cells with concomitant 
reduction  in  tumorigenicity (1).  In  the  present 
study some of the biochemical parameters accom- 
panying resistance to actinomycin D were investi- 
gated.  Recently, other cell  lines have been devel- 
oped which  are resistant to actinomycin D (4,  11, 
12) and which exhibit altered growth patterns when 
compared to parental cells.  The sensitive parental 
DC-3F line takes  up over 50 times more labeled 
antibiotic than the  most  resistant DC-3F/AD X 
subline. Similar results were  reported  earlier for 
HeLa  cells  by  Goldstein  et  al.  (2),  and  more 
recently for murine leukemia cells by Kessel and 
Bosmann (I 3). 
The  Chinese  hamster  cells  most  resistant  to 
actinomycin D,  DC-3F/AD X,  require over 250 
times more antibiotic to  shut off RNA synthesis 
than do sensitive parental DC-3F cells and over 10 
times more than do  Vero  cells  (14).  Preliminary 
experiments indicate that the highly resistant cells 
have a reduced capacity to transport uridine. Since 
it  has  been  known  for  some  time  that  contact- 
inhibited cells have a reduced capacity to incorpo- 
rate  uridine  (15,  16,  17), the  possibility  of  a 
density-dependent  inhibitory  effect  on  uridine 
transport  was  experimentally excluded.  The  fact 
that the growth rates and the total RNA content of 
the  sensitive and parental cells are similar would 
suggest that the  actual rate of RNA  synthesis is 
also  quite  similar. This  could  be  established  by 
measuring pool sizes. 
Results of efflux experiments suggest that resist- 
ance to  actinomycin D  in these  Chinese hamster 
cells is not due to rapid uptake and release of drug. 
Sawicki and Godman (14)  have shown that Vero 
cells  have  greater  natural  resistance  to  ac- 
tinomycin D than either HeLa or L cells. However, 
when the cells  are preioaded with  actinomycin D, 
Vero cells excrete bound antibiotic about twice as 
fast  as  HeLa  or  L  cells,  independent of time of 
exposure or internal drug concentration. 
Uptake  of  actinomycin D  is  temperature  de- 
pendent  in  both  sensitive and  resistant  Chinese 
hamster cells.  Kessel and Wodinsky (18) reported 
a similar finding for Li210 cells. The observation 
that  drug  uptake  was  not  inhibited  in  either 
sensitive or resistant cells in the presence of various 
metabolic inhibitors suggests that actinomycin D 
is not actively transported. 
Resistance  to  actinomycin  D  might  also  be 
explained by metabolism and breakdown to a less 
toxic  substance.  However,  we  observed  no  evi- 
dence of breakdown after growth of resistant cells 
for 72 h in the presence of antibiotic. 
Actinomycin D-resistant Chinese hamster cells 
were  previously  shown  to  be  cross-resistant  to 
puromycin,  as  well  as  to  a  variety  of  other 
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weight range of approximately 350 to  1,300 (3). In 
the present study we show that cross-resistance to 
puromycin  is  due  to  reduced  permeability  of 
DC-3F/AD  X  cells to this antibiotic. Thus, cellu- 
lar resistance to both actinomycin D  and puromy- 
cin  appears to be the consequence of an impaired 
mechanism  of  uptake  of  antibiotic  into  the  cell. 
Increased adhesiveness and altered surface constit- 
uents  of  resistant  cells  may  in  some  manner 
contribute to the permeability barrier at the level 
of  the  plasma  membrane.  Alterations  of plasma 
membrane  components  in  resistant cells  are  cur- 
rently being investigated in our laboratory. 
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